Controversial Weight-Loss Drug Approved For NHS Use In Britain

The controversial anti-obestity drug rimonabant, marketed as Acomplia, has been approved for National Health Service (NHS) use in the England and Wales. The National Institute for Healthcare and Clinical Excellence (NICE) has approved use of this diet drug in people who are clinically obese or people who are seriously overweight with complications such as diabetes. The drug, made by Sanofi-Aventis, is approved for sale in Britain and elsewhere in the European Union but was rejected by a U.S. Foo